Organization
Genentech, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Genentech, Inc.
... As Roche braces for the biosimilar assault on blockbuster cancer drugs, its Genentech unit is parting ways with 223 staffers in California. In a WARN ...
... Analysis of key players in Next generation biologics Market · Abbvie · Roche/ Genentech · Amgen · GSK · Eli Lilly · Sanofi Aventis · ...
... and clinical development at Bristol-Myers Squibb, Five Prime Therapeutics, Clovis Oncology and Genentech. Currently Senior Vice President, Chief Medical Officer and Head of Development at ...
... is the difference between $33 billion and $19 billion? If you are Genentech, it is $190 million in taxes and sometimes years of tax litigation. ...
... Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced ...
... lot less than what county tax assessors say. In the Bay Area, Genentech and Apple are particularly aggressive in opposing tax assessors - elected officials ...
... (SACRAMENTO) -Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test ...
... the combination of BL-8040 and Merck's KEYTRUDA and a collaboration agreement with Genentech, a member of the Roche Group, to investigate the combination of BL-8040 ...
... c-Met signaling tumors. "The clinical trial we are fielding in collaboration with Genentech and the NSABP Foundation is continuing to progress. The institutional review board ...
... mAbs against VEGF have been established since FDA approval of Bevacizumab (Avastin, Genentech/Roche) in year 2004. Since, Avastin, FDA has approved ranibizumab (Lucentis, Genentech/Roche) and ...
Subscribe now for full coverage on Genentech, Inc.
Start My Free Trial